Beijing YouAn Hospital

Running trials

• Not yet recruiting

  Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response

  NCT07797231· Phase 3· Source

• Recruiting

  A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA

  NCT07282353· Phase 3· Source

• Recruiting

  A Phase Ⅱa Clinical Study of CL-197 Capsules

  NCT07308782· Phase 2· Source

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Source

• Not yet recruiting

  CPET-based HIIT for MAFLD

  NCT07177963· Source

• Recruiting

  Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion

  NCT07170345· Source

• Not yet recruiting

  Prognostic Model for MASLD Related Cirrhosis

  NCT07082751· Source

• Not yet recruiting

  The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

  NCT06773221· Source

• Recruiting

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  NCT06632457· Phase 3· Source

• Recruiting

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· Phase 3· Source

• Recruiting

  A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B

  NCT06525909· Source

• Recruiting

  Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

  NCT05939167· Phase 1/2· Source

• Recruiting

  Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

  NCT06051617· Phase 3· Source

• Recruiting

  Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis

  NCT05905172· Phase 3· Source

• Active, not recruiting

  CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

  NCT05896124· Phase 2· Source

• Recruiting

  Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

  NCT05862337· Phase 3· Source

• Enrolling by invitation

  A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B

  NCT06707922· Source

• Active, not recruiting

  A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

  NCT05050136· Phase 2· Source

• Active, not recruiting

  A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)

  NCT04344158· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)6 recruiting
• Hepatitis B4 recruiting
• HIV2 recruiting
• Liver and biliary tract cancer2 recruiting
• Primary biliary cholangitis2 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected Subjects

  NCT06990776· Phase 2· Source

• Completed

  Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection

  NCT06644417· Phase 2· Source

• Terminated

  A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)

  NCT06487559· Phase 1· Source

• Completed

  Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GKL-006 Injection in Combination With TACE in Unresectable Hepatocellular Carcinoma

  NCT07845266· Phase 1· Source

• Completed

  A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

  NCT05877547· Phase 2· Source

• Terminated

  Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B

  NCT05760703· Phase 2· Source

• Terminated

  To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B

  NCT05760781· Phase 2· Source

• Completed

  A Study to Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level Viremia

  NCT05734807· Phase 2· Source

• Terminated

  A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

  NCT05161481· Phase 2· Source

• Completed

  A Phase II Clinical Trial of Chiglitazar for NASH

  NCT05193916· Phase 2· Source

• Completed

  Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection

  NCT06544551· Phase 3· Source

• Completed

  A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B

  NCT04846491· Phase 3· Source

• Completed

  Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults

  NCT03547908· Phase 3· Source

• Completed

  A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)

  NCT03412773· Phase 3· Source

Trial sites

• Beijing YouAn Hospital4 trials
• Beijing Youan Hospital,Capital Medical2 trials
• Beijing YouAn Hospital,Capital Medical University23 trials
• Beijing Youan Hospital, Capital Medical Universitybeijing Institute of Hepatology1 trial
• Beijing Youan Hospital, Capital Medical University -No differernce with previous /ID# 2619281 trial
• Beijing Youan Hospital (Site 0602)1 trial
• Beijing youan hospital, the capital of the capital1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• HIV93 works · 2 trials
• Liver and biliary tract cancer77 works · 6 trials
• Hepatitis B25 works · 12 trials
• Primary biliary cholangitis9 works · 4 trials